NZ227123A - Pharmaceutical compositions containing 5-((s)-1-hydroxy-2-((r)-(1-methyl-3-phenyl(propyl)-amino)-ethyl)-salicylamide - Google Patents

Pharmaceutical compositions containing 5-((s)-1-hydroxy-2-((r)-(1-methyl-3-phenyl(propyl)-amino)-ethyl)-salicylamide

Info

Publication number
NZ227123A
NZ227123A NZ227123A NZ22712388A NZ227123A NZ 227123 A NZ227123 A NZ 227123A NZ 227123 A NZ227123 A NZ 227123A NZ 22712388 A NZ22712388 A NZ 22712388A NZ 227123 A NZ227123 A NZ 227123A
Authority
NZ
New Zealand
Prior art keywords
salicylamide
propyl
hydroxy
phenyl
ethyl
Prior art date
Application number
NZ227123A
Other languages
English (en)
Inventor
William Darrow
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NZ227123A publication Critical patent/NZ227123A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ227123A 1987-11-30 1988-11-29 Pharmaceutical compositions containing 5-((s)-1-hydroxy-2-((r)-(1-methyl-3-phenyl(propyl)-amino)-ethyl)-salicylamide NZ227123A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/126,441 US4788183A (en) 1987-11-30 1987-11-30 Method for treatment of dyslipidemia in humans

Publications (1)

Publication Number Publication Date
NZ227123A true NZ227123A (en) 1990-08-28

Family

ID=22424849

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ227123A NZ227123A (en) 1987-11-30 1988-11-29 Pharmaceutical compositions containing 5-((s)-1-hydroxy-2-((r)-(1-methyl-3-phenyl(propyl)-amino)-ethyl)-salicylamide

Country Status (10)

Country Link
US (1) US4788183A (OSRAM)
EP (2) EP0318889A3 (OSRAM)
JP (1) JPH02503314A (OSRAM)
KR (1) KR890701111A (OSRAM)
AU (1) AU2816889A (OSRAM)
DK (1) DK132090D0 (OSRAM)
HU (1) HUT53526A (OSRAM)
NZ (1) NZ227123A (OSRAM)
WO (1) WO1989005146A2 (OSRAM)
ZA (1) ZA888993B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
US6264960B1 (en) 1998-11-10 2001-07-24 Sander J. Robins Treatment of vascular events using lipid-modifying compositions
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
WO2006020999A2 (en) * 2004-08-19 2006-02-23 The United States Of America, As Represented By The Secretary Of Agriculture Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
ZA794872B (en) * 1978-09-20 1980-11-26 Schering Corp A phenylalkylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide

Also Published As

Publication number Publication date
ZA888993B (en) 1989-07-26
AU2816889A (en) 1989-07-05
US4788183A (en) 1988-11-29
KR890701111A (ko) 1989-12-19
WO1989005146A3 (en) 1989-10-19
JPH0532368B2 (OSRAM) 1993-05-14
HU890492D0 (en) 1990-09-28
JPH02503314A (ja) 1990-10-11
EP0318889A2 (en) 1989-06-07
DK132090A (da) 1990-05-29
DK132090D0 (da) 1990-05-29
WO1989005146A2 (en) 1989-06-15
EP0318889A3 (en) 1989-11-29
HUT53526A (en) 1990-11-28
EP0391958A1 (en) 1990-10-17

Similar Documents

Publication Publication Date Title
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
GB8810477D0 (en) Pharmaceutical compositions
IL115973A (en) Acylated insulin analogs and pharmaceutical compositions containing them
GB8710965D0 (en) Pharmaceutical compositions
NZ223875A (en) 9-aminotetrahydroacridines and related homologues and pharmaceutical compositions
GB8826321D0 (en) Pharmaceutical compositions
GB2207034B (en) Anti-denaturation agents for edible protein compositions
GB8718619D0 (en) Pharmaceutical compositions
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
GB8804697D0 (en) Pharmaceutical compositions
NZ227123A (en) Pharmaceutical compositions containing 5-((s)-1-hydroxy-2-((r)-(1-methyl-3-phenyl(propyl)-amino)-ethyl)-salicylamide
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
IL83715A0 (en) Pharmaceutical anti-protozoal compositions
GB8810716D0 (en) Pharmaceutical compositions
GB8713091D0 (en) Pharmaceutical compositions
ZW14688A1 (en) Pharmaceutical compositions
IL94937A0 (en) Pharmaceutical compositions containing acrylic acid derivatives
ZA882861B (en) Pharmaceutical compositions
IL93649A0 (en) Pharmaceutical composition containing n-acetylneuraminic acid
IL83177A0 (en) Pharmaceutical compositions containing xylometazoline
GB8827838D0 (en) Pharmaceutical compositions
GB8728689D0 (en) Amino acid pharmaceutical compositions
GB8716784D0 (en) Pharmaceutical compositions
GB8700812D0 (en) Pharmaceutical compositions
GB8711680D0 (en) Pharmaceutical compositions